Micronized Fenofibrate in Dyslipidemia: A Focus on Plasma High-Density Lipoprotein Cholesterol (HDL-C) Levels

By Sharpe M.   Ormrod D.   Jarvis B.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 2, 2002-02 ,pp. : 125-132

Adis International

Access to resources Recommend Favorite

The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia

By Nakou ES   Filippatos TD   Kiortsis DN   Derdemezis CS   Tselepis AD   Mikhailidis DP   Elisaf MS  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3151-3158

Informa Healthcare

Access to resources Recommend Favorite

Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3841-3857

Bentham Science Publishers

Access to resources Recommend Favorite

Low High-Density Lipoprotein Cholesterol: Physiological Background, Clinical Importance and Drug Treatment

By Hersberger M.   von Eckardstein A.  

Drugs, Vol. 63, Iss. 18, 2003-01 ,pp. : 1907-1945

Adis International

Access to resources Recommend Favorite

Therapeutic use of the high-density lipoprotein protein and peptides

By Marchesi Marta   Sirtori Cesare R  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 227-241

Informa Healthcare

Access to resources Recommend Favorite